FNY Investment Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-500
Closed -$2K 573
2022
Q3
$2K Sell
500
-100
-17% -$630 ﹤0.01% 539
2022
Q2
$3K Buy
600
+575
+2,300% +$6.4K ﹤0.01% 547
2022
Q1
$0 Buy
+25
New +$573 ﹤0.01% 802

Other funds holding GDRX

FNY Investment Advisers's GDRX Position: Q4 2022 in Review

FNY Investment Advisers sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 500 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in GDRX in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

  • FNY Investment Advisers reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 500 GoodRx Holdings shares in Q4 2022, an estimated $2K.
  • FNY Investment Advisers first reported a position in GoodRx Holdings in Q1 2022 and held it in 3 quarters.
  • FNY Investment Advisers's GoodRx Holdings position peaked at $3K in Q2 2022.
  • 160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on FNY Investment Advisers's 13F filing for Q4 2022, filed 10 Jan 2023.